دورية أكاديمية

Frequency and prognostic significance of access site and non-access site bleeding and impact of choice of antithrombin therapy in patients undergoing primary percutaneous coronary intervention. The EUROMAX trial

التفاصيل البيبلوغرافية
العنوان: Frequency and prognostic significance of access site and non-access site bleeding and impact of choice of antithrombin therapy in patients undergoing primary percutaneous coronary intervention. The EUROMAX trial
المؤلفون: Kilic, Sinem, van't Hof, Arnoud W.J., ten Berg, Jurrien, Lopez, Ana Ayesta, Zeymer, Uwe, Hamon, Martial, Soulat, Louis, Bernstein, Debra, Deliargyris, Efthymios N., Steg, Phillippe Gabriel
المصدر: In International Journal of Cardiology 15 May 2016 211:119-123
قاعدة البيانات: ScienceDirect
الوصف
تدمد:01675273
DOI:10.1016/j.ijcard.2016.02.131